Koo ... yes, many factors to consider, and complexities. In the event of a future buy out for $4-8b ($20-32 pps ish) for example ... both KD and Hepa could find "peace and happiness" potentially, in that type of ROI on their $2.60 investment, hopefully? Maybe? ... especially if THIS path (BP partnering) helps make that a more certain, or at least more likly scenario, without having to dig deeper?

Hepa though, specifically, and as a condition to go along with a "yes" vote, could pound the table for an eventual manufacturing/marketing/distribution opportunity and rights in Asia/Africa? ... in addition to their potentially rich ROI on RVX stock? ... who could blame them?! BP may say, okay deal, the market is significant enough in North America, South America, and Europe, but here is an additional discount factor to the purchase price for giving up access to Asia/Africa?

Without knowing the level and tenor of current conversations, we just don't know how and what the onion looks like as it is peeled back during discussion ... could be a myriad of options to appease all, being discussed, and evaluated for contingency deals on the back end of the top goal of finding a path to success and commercialization?

As a matter of fact, this is ALL guess work (for fun, during quarantine haha), ... since we (or at least most of us) here on agora don't know what is actually going on behind the curtain.

Just utilizing our varied experiences, perspectives, and expertise to interpret a very odd work of art hanging on the wall right now, at the Lourve (or Guggenheim if preferable) ... haha